Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01093 CSPC PHARMA
RT Nominaldown5.330 -0.140 (-2.559%)
Block Trade News
More
26/09/2024 14:12
{Block Trade}CSPC PHARMA (01093): 6.53m shares, or HK$35.49m
[ET Net News Agency, 26 September 2024] A direct manual trade of 6.53 million shares ofCSPC PHARMA (01093) was registered at 2:11p.m. The deal amo ... View All View All

23/09/2024 09:55    {Block Trade}CSPC PHARMA (01093): 7.41m shares, or HK$37.07m

06/06/2024 13:19    {Block Trade}CSPC PHARMA (01093): 8.36m shares, or HK$58.12m

03/06/2024 09:01    {Block Trade}Pre-opening block trades at 9:00am (1)

Research Report
More
22/08/2024 15:52
{I-bank focus}Citi lowers CSPC Pharma (01093) to HKD10
[ET Net News Agency, 22 August 2024] Citi lowered the target price for CSPC Pharma (01093) to HKD10 from HKD13 and maintained the "buy" rating. Th ... View All View All

31/05/2024 15:01    {I-bank focus}Goldman raises CSPC Pharma (01093) to HKD10.26

28/05/2024 15:51    {I-bank focus}Daiwa raises CSPC Pharma (01093) to HKD8

28/05/2024 15:10    {I-bank focus}UBS raises CSPC Pharma (01093) to HKD10.1

Remark: Real time quote last updated: 06/11/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.